Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1970-7-23
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-9074
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
259-66
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:5419245-Adult,
pubmed-meshheading:5419245-Aged,
pubmed-meshheading:5419245-Female,
pubmed-meshheading:5419245-Humans,
pubmed-meshheading:5419245-Hypertension,
pubmed-meshheading:5419245-Hypertension, Renal,
pubmed-meshheading:5419245-Male,
pubmed-meshheading:5419245-Methyldopa,
pubmed-meshheading:5419245-Middle Aged
|
pubmed:year |
1970
|
pubmed:articleTitle |
[Treatment of hypertensive patients with alphamethyldopa].
|
pubmed:publicationType |
Journal Article
|